Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

O efeito da terapia da dignidade aplicada a pacientes com câncer

5 de outubro de 2026 atualizado por: NESIBE GÜNAY MOLU, Necmettin Erbakan University

O efeito da terapia da dignidade aplicada a pacientes com câncer em estágio terminal na dignidade percebida e na autoestima: um ensaio clínico randomizado

The aim of this study is to determine the effect of dignity therapy on the quality of life and depression levels of cancer patients.

Methods: The research was planned as a randomized controlled experimental study.

Type of Research: Research, experimental, control group and pretest-posttest study will be carried out.

Population of the Study: The population of the study was sent to Meram Medical Faculty Hospital Oncology Clinic consists of male and female inpatients.

Sample of the Research: Those who agreed to participate in the research and met the inclusion criteria. Patients who meet will be included in the study. It was 48. It was planned to be.

Randomization: In this study, parallel group block randomization method was applied to the intervention and control groups. will be allocated randomly. Block randomization was used because the sample size was small. Patients will be selected equally using permutation method, and randomization will be selected using blocking technique. will be done. During randomization, CONSORT 2017 will be used.

For randomization; To control for performance bias, patients will be blinded to the study hypothesis and will not be informed which group they are in. There will be no blinding for the researcher. However, blind technique will be used in the research. This blind technique will be applied by the researcher with the patients blinded until the application begins..

Data Collection Techniques and Tools: "Personal Information Form", "Patient Dignity Inventory" and "Rosenberg Self-Esteem Scale" were used in data collection (RSES)" will be used.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

Cancer affects both the patient and their relatives physically and psychologically. From the moment cancer is diagnosed, psychological problems that affect the adaptation processes of individuals, which can be defined as crises, may arise along with the physical effects of the disease and the treatment process. It is suggested that the loss of dignity that develops in terminally ill patients causes the patients to want to die as soon as possible. It is important that patients receive care in accordance with the standards and value judgments they are used to, so that their sense of dignity and status is not affected by health problems. Dignity therapy is a type of short-term therapy developed to alleviate the distress of terminally ill patients and improve their end-of-life experiences. Chochinov emphasizes that dignity depends on productivity experiences, the search for purpose and meaning, defined dignity-protective care for patients facing a serious illness, and developed a model to be developed, studied and used by clinicians.

In the literature, it is seen that dignity therapy can be applied by different health professionals in patient groups with different diagnoses and provides positive contributions for patients and their relatives. With the increase in palliative care units in recent years, it has been considered important to apply this type of therapy to patients. In addition, no studies on dignity therapy have been found in Turkey. The aim of this study is to determine the effect of dignity therapy on the quality of life and depression levels of cancer patients.

Methods: The research was planned as a randomized controlled experimental study. Research Outpatient and inpatient treatment at Necmettin Erbakan University Faculty of Medicine hospital oncology clinic It will be done with end-stage cancer patients. October 2023-December 2023 with an average of 48 patients It will be carried out between . In collecting research data, Personal Information Form, Patient The Reputation Inventory and the Rosenberg Self-Esteem Scale (RSES) will be used.

Type of Research: Research, experimental, control group and pretest-posttest study will be carried out.

Place and Characteristics of the Research: The research was conducted in Konya province by Necmettin Erbakan It will be carried out in the Oncology clinic of University Meram Faculty of Medicine Hospital.Inpatient clinics are located on the 3rd and 4th floors, and there are 33 beds on each floor. Population of the Study: The population of the study was sent to Meram Medical Faculty Hospital Oncology Clinic consists of male and female inpatients.

Sample of the Research: Those who agreed to participate in the research and met the inclusion criteria. Patients who meet will be included in the study. The sample size in this study In order to determine the results, a priori power analysis was performed with the G-Power 3.1 statistical program. In determining the sample size, "The effect of Chinese culture-adapted dignity therapy on advanced cancer patients receiving chemotherapy in the Scores obtained from the "day oncology unit: A quasi-experimental study" study were used. 95% confidence (1-α), 80% test power (1-β), With an effect size of f = 0.78, the minimum number of samples to be included in the study was determined as 44 in total, 22 in each group. Patients are excluded from the study for many reasons. It was thought that there might be a loss of approximately 10% due to separation, and the number of samples was 48. It was planned to be.

Randomization: In this study, parallel group block randomization method was applied to the intervention and control groups. will be allocated randomly. Block randomization was used because the sample size was small. Patients will be selected equally using permutation method, and randomization will be selected using blocking technique. will be done. During randomization, CONSORT 2017 (Randomized Parallel Group Updated Guidelines for Reporting Research) will be used.

For randomization; To control for performance bias, patients will be blinded to the study hypothesis and will not be informed which group they are in. There will be no blinding for the researcher. However, blind technique will be used in the research. This blind technique will be applied by the researcher with the patients blinded until the application begins. In the research, in order to meet the blind technical conditions, the process steps were carried out by an independent statistician from the first stage. The sample will be sorted by a combination order and number. In this way selection bias will be controlled. The study will also be controlled for attrition bias and Statistics and reporting bias.

Data Collection Techniques and Tools: "Personal Information Form (sociodemographic and disease characteristics)", "Patient Dignity Inventory" and "Rosenberg Self-Esteem Scale" were used in data collection (RSES)" will be used.

Data Collection Tools Personal Information Form: The form created by the researcher by scanning the literature consists of 8 questions (age, gender, marital status, employment status, monthly income level, education level, cancer type, how long ago it was diagnosed).

Patient Dignity Inventory: The scale, consisting of a total of 25 items and translated into Turkish adapted. This five-point Likert type inventory is rated as "1 = no problem, 2 = slight problem, 3 = problem, 4 = big problem, 5 = very much problem." The minimum and maximum total score of the inventory is 25 and 125 points respectively. There are no reverse scored items in the inventory. A higher total score means that the individual's perceived reputation is complex. Items scoring three or more are clinically meaningful. As a result of factor analysis, a five-factor structure was obtained; The factors are reported as "symptom distress", "existential distress", "addiction", "peace of mind" and "social support". The Cronbach alpha value of the scale was reported as 0.94.

Rosenberg Self-Esteem Scale (RSES): Participants score the questions as very true, true, false and very false. This scale, developed by Rosenberg, consists of a total of 63 items and 12 subtests. Self-Esteem Scale, one of these 12 subtests, was used in this study. The scale consists of a total of 10 items, 5 negative and 5 positive items. For questions 1, 2, 4, 6 and 7, respectively, it is very true (4), true (3), wrong (2), very wrong (1). The opposite is true for articles 3, 5, 8, 9 and 10. A high score on Rosenberg self-esteem means low self-esteem. A scale adaptation study was conducted. As a result of this study, the test-retest reliability of the scale was found to be 0.75. The validity coefficient of the scale was found to be 0.71.

Application Steps: After the patients coming to the oncology clinic as outpatients or inpatients are evaluated by their physicians, they will be referred to the researcher if the predicted survival time is less than 6 months. The purpose of the study will be explained to patients who meet the inclusion criteria, and for those who accept, planning will be made in a way that will not disrupt the patient's treatment process, and the steps applied in dignity therapy will be followed. Dignity therapy will be applied in the interview room that will be requested in the oncology clinic to protect the confidentiality of information.

The application is planned as five sessions and the sessions will last approximately 40 minutes. Two questions in the dignity therapy protocol will be discussed in each session. Dignity Therapy Necmettin Erbakan University Faculty of Nursing, Department of Mental Health and Diseases Nursing. Lecturer It will be carried out by the researcher who serves as a member. She has worked as a clinical nurse researcher and is an expert in psychiatric nursing. Before the researcher started to apply this therapy, the 3-day "Dignity in Care - Online Training 2023" (https://www.cpd-umanitoba.com/events/dignityin-care-online-training) was held online between 14-28 September 2023. -2023/) attended the course. The course is hosted by Harvey Max Chochinov, a Distinguished Professor of Psychiatry at the University of Manitoba and Senior Scientist at the Cancer Care Manitoba Research Institute.

The therapist will interview each participant individually, it will be conducted in accordance with the dignity therapy protocol, the interviews will be recorded with a voice recorder, all recorded conversations will be transcribed and read to the patient after a preliminary arrangement.

A discussion will be held on the areas that the patient wishes to change in the text, and as included in the dignity therapy protocol, a session organization process will be carried out with the participant, especially in the last session, in which the participant will be provided with a written legacy (certificate of productivity). The Dignity therapist prepares a document to be transferred to the participants' families, relatives or friends, with patient approval. It will be made ready to be given after submission. The Dignity therapist will create a written report at the end of the interviews to be given to their families and present this report to the patients. The final version of the report will be given by the patients.

Data Collection: Data will be collected by the researcher through face-to-face interviews in the oncology clinic at Necmettin Erbakan University Faculty of Medicine Hospital, from patients who meet the inclusion criteria and agree to participate in the study, without disrupting the working order of the clinic. Data collection forms will be applied to both the experimental and control groups as a pretest before dignity therapy begins to be applied to the participants (in the 1st session) and as a posttest after dignity therapy is completed (in the last session). Data collection tools will be filled in the patient room, respecting the patient's privacy.

Research Variables Dependent variables: Patient Dignity Inventory, Rosenberg Self-Esteem Scale Independent variables: Sociodemographic and disease characteristics, applied dignity therapy Control variables: Age, gender Ethical Dimension of the Research: Permission for the research was received from Necmettin Erbakan University Health Sciences Scientific Research Ethics Committee and the Faculty of Medicine Hospital Oncology Clinic. Permission will be obtained via e-mail from the authors of the scales to be used. Participants who will participate in the research will be given verbal information about the research and Informed Consent Form will be signed.

Participants who do not agree to participate in the research will not be forced to participate. There is no conflict of interest between the researchers.

Statistical Evaluation of Data: Statistical analysis will be done using SPSS 23.0 (Statistical Package for Social Sciences Version 23.0) program. Cronbach's Alpha analysis will be used in the internal consistency examination to determine the validity and reliability of the scale, descriptive statistics will be used to determine the findings regarding the individual characteristics of the participants, median and minimum/maximum values for non-normally distributed variables, and mean±standard deviation values for normally distributed variables. Appropriate statistical analyzes regarding the hypotheses will be used to compare independent variables. The results obtained will be tested at the p<0.05 significance level.

Tipo de estudo

Intervencional

Inscrição (Real)

48

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Meram
      • Konya, Meram, Turquia (Türkiye), 42090
        • Necmettin Erbakan Üniversitesi

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Inclusion Criteria for Participants in the Study:

    • Able to speak and understand Turkish,
    • Those over 18 years of age
    • No communication barriers
    • Cancer diagnosis is in the 4th stage and in the last stage
    • Patients with a predicted survival time of less than 6 months (physician opinion) will be included

Exclusion Criteria:

  • Criteria for Exclusion of Participants in the Study:

    • Those diagnosed with dementia, delirium or other organic brain disorders;
    • Those with impaired consciousness;
    • Patients with mental problems that prevent them from receiving esteem therapy will be excluded

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: experimental group

Patients in this group will be treated with dignity therapy by the researcher.

Dignity therapy will be applied in the interview room that will be requested in the oncology clinic to protect the confidentiality of information.

The application is planned as five sessions and the sessions will last approximately 40 minutes. Two questions in the dignity therapy protocol will be discussed in each session.

Comparador Ativo: control group

Patients in this group will receive standard care and no treatment will be performed by the researcher.

The control group will receive routine clinical care as provided by the oncology clinic. No additional psychological or supportive intervention will be administered by the researchers to this group during the study period.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Patient Dignity Inventory
Prazo: Baseline (Day 0) and Day 10

The scale, consisting of a total of 25 items, was developed by Chochinov et al. (2008) and translated into Turkish by Eskigülek and Kav (2022) adapted. The minimum and maximum total score of the inventory is 25 and 125 points respectively. There are no reverse scored items in the inventory. A higher total score means that the individual's perceived reputation is complex. Items scoring three or more are clinically significant. As a result of factor analysis, a five-factor structure was obtained; The factors are reported as "symptom distress", "existential distress", "addiction", "peace of mind" and "social support"

Baseline (Day 0) and Day 10

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Personal Information Form
Prazo: Baseline (Day 0) and Day 10

The form created by the researcher by scanning the literature consists of 8 questions

Baseline (Day 0) and Day 10
Rosenberg Self-Esteem Scale
Prazo: Baseline (Day 0) and Day 10

The Rosenberg Self-Esteem Scale was developed by Morris Rosenberg in 1965 to measure the self-esteem of adolescents (Rosenberg, 1965). Participants score the questions as very true, true, false and very false. This scale, developed by Rosenberg, consists of a total of 63 items and 12 subtests. Self-Esteem Scale, one of these 12 subtests, was used in this study. The scale consists of a total of 10 items, 5 negative and 5 positive items. A high score on Rosenberg self-esteem means low self-esteem.

Baseline (Day 0) and Day 10

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: NESIBE GÜNAY MOLU, Necmettin Erbakan University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

12 de janeiro de 2023

Conclusão Primária (Real)

15 de setembro de 2025

Conclusão do estudo (Real)

15 de setembro de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

18 de outubro de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de outubro de 2023

Primeira postagem (Real)

27 de outubro de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

5 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • Necmettin Erbakan University1

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Data will not be shared due to protection of patient confidentiality and institutional rules.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever